Stay updated on Favezelimab Combo vs Standard in Metastatic CRC Clinical Trial
Sign up to get notified when there's something new on the Favezelimab Combo vs Standard in Metastatic CRC Clinical Trial page.

Latest updates to the Favezelimab Combo vs Standard in Metastatic CRC Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRevision: v3.5.0 was added to the history and Revision: v3.4.3 was removed. This reflects an update to the revision log rather than changes to study data or user-facing content.SummaryDifference0.1%

- Check28 days agoChange DetectedRevision: v3.4.3 was added to the history, and Revision: v3.4.2 was removed.SummaryDifference0.1%

- Check57 days agoChange DetectedRevision: v3.4.2 was added and older notices (Revision: v3.4.1 and a government funding status notice) were removed, indicating a UI/version update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check64 days agoChange DetectedA new revision v3.4.1 was added and v3.4.0 removed, and a site-wide notice regarding government funding and NIH operations was introduced. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check71 days agoChange DetectedUI/formatting updates on the history page include a glossary toggle, color-coded change indicators (green for additions, red for deletions), and updated revision metadata to v3.4.0. The capitalization of the No FEAR Act label was adjusted.SummaryDifference0.5%

- Check85 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4, indicating a minor site update with no changes to study data or history details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Favezelimab Combo vs Standard in Metastatic CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Favezelimab Combo vs Standard in Metastatic CRC Clinical Trial page.